Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
European Journal of Haematology
|
April 23, 2010
The clinical and biological features of a series of immunophenotypic variant of B-CLL
Lilla Cro, Andrea Ferrario, Marta Lionetti, et al.
Current Research in Translational Medicine
|
October 1, 2021
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type
Lorenzo Lazzari, Francesca Farina, Maria Teresa Lupo Stanghellini, et al.
Journal of Medical Internet Research
|
February 19, 2025
Finding Consensus on Trust in AI in Health Care: Recommendations From a Panel of International Experts
Georg Starke, Felix Gille, Alberto Termine, et al.
American Journal of Hematology
|
November 23, 2017
Secondary acute myeloid leukaemia in elderly patients: Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions. An analysis of 280 patients by the network rete ematologica lombarda (REL)
Erika Borlenghi, Chiara Pagani, Patrizia Zappasodi, et al.
Bone Marrow Transplantation
|
October 12, 2021
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation
Marco Salvini, Fabrizio Maggi, Camilla Damonte, et al.
Blood
|
August 3, 2022
Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL
Lydia Scarfò, Silvia Heltai, Elisa Albi, et al.
Haematologica
|
May 12, 2018
Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the <i>Fondazione Italiana Linfomi</i>
Sergio Storti, Michele Spina, Emanuela Anna Pesce, et al.
Leukemia & Lymphoma
|
March 28, 2022
How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia
Marina Deodato, Anna Maria Frustaci, Paolo Sportoletti, et al.
Bone Marrow Transplantation
|
June 17, 2020
Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi
Michele Merli, Stefano Luminari, Lucia Farina, et al.
Hematological Oncology
|
July 14, 2021
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report
Antonio Cuneo, Gian Matteo Rigolin, Marta Coscia, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
European Journal of Haematology
|
April 23, 2010
The clinical and biological features of a series of immunophenotypic variant of B-CLL
Lilla Cro, Andrea Ferrario, Marta Lionetti, et al.
Current Research in Translational Medicine
|
October 1, 2021
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type
Lorenzo Lazzari, Francesca Farina, Maria Teresa Lupo Stanghellini, et al.
Journal of Medical Internet Research
|
February 19, 2025
Finding Consensus on Trust in AI in Health Care: Recommendations From a Panel of International Experts
Georg Starke, Felix Gille, Alberto Termine, et al.
American Journal of Hematology
|
November 23, 2017
Secondary acute myeloid leukaemia in elderly patients: Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions. An analysis of 280 patients by the network rete ematologica lombarda (REL)
Erika Borlenghi, Chiara Pagani, Patrizia Zappasodi, et al.
Bone Marrow Transplantation
|
October 12, 2021
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation
Marco Salvini, Fabrizio Maggi, Camilla Damonte, et al.
Blood
|
August 3, 2022
Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL
Lydia Scarfò, Silvia Heltai, Elisa Albi, et al.
Haematologica
|
May 12, 2018
Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the <i>Fondazione Italiana Linfomi</i>
Sergio Storti, Michele Spina, Emanuela Anna Pesce, et al.
Leukemia & Lymphoma
|
March 28, 2022
How COVID-19 pandemic changed our attitude to venetoclax-based treatment in chronic lymphocytic leukemia
Marina Deodato, Anna Maria Frustaci, Paolo Sportoletti, et al.
Bone Marrow Transplantation
|
June 17, 2020
Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi
Michele Merli, Stefano Luminari, Lucia Farina, et al.
Hematological Oncology
|
July 14, 2021
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report
Antonio Cuneo, Gian Matteo Rigolin, Marta Coscia, et al.
Page
of 7